PHILADELPHIA, Nov. 30, 2016 /PRNewswire/ -- ACI Clinical, the leading independent specialty provider of Endpoint Adjudication and Data Monitoring Committees to the clinical trial industry, is proud to announce the addition of two new executives, Andrew MacKnight and Amit Bhattacharyya. Both are seasoned industry professionals with successful track records managing organizational growth.
"Timing is perfect to welcome Andrew and Amit into the company as we are continuing to build more and more pharma, biotech and device client partnerships to support global expert committee operations," says Amy Ghelardi, Director of Client Services. "Andrew and Amit have a great deal of management experience and I am confident that their operational expertise and leadership will benefit our clients looking to outsource the setup and management of their committees to ACI for a fully integrated, standardized approach that can easily be applied study to study."
Andrew MacKnight joined ACI Clinical as Vice President of Operations with a background in strategic product development and business management in the Life Sciences industry. His experience in the CRO sector includes leadership of commercial operations at Covance, and responsibility for acquisitions and integration at inVentiv Health Clinical. He also spent over 12 years at GlaxoSmithKline in strategic product development roles with an emphasis on global vaccines and public health.
Amit Bhattacharyya joined ACI Clinical as Vice President of Biometrics to lead the Statistics and Programming functions, bringing 23 years of his GSK experience in the applied statistics and programming fields. At GSK, he served in technical, leadership and global management roles while supporting R&D studies in Preclinical Discovery, Clinical Development and Health Outcomes disciplines. He brings rich experiences from working globally in the UK, India and US, and from his involvement in various statistical societies over the years.
ACI Clinical president, Dr. Jonathan Seltzer, commented: "We're thrilled to add Andrew and Amit to our team. Their decades of leadership experience at major companies enhances our scalability and expertise."
About ACI Clinical ACI Clinical is a niche provider of clinical trial committees and clinical trial advisory services. The company offers the largest committee dedicated staff in the industry, its own global network of more than 500 experienced clinicians, and proprietary technologies designed specifically to enable streamlined committee processes. Company executives maintain involvement in public-private thought leadership efforts to improve the quality and effectiveness of clinical trials, and currently participate in projects with the Cardiac Safety Research Consortium (CSRC), the Clinical Trials Transformation Initiative (CTTI), the Clinical Data Interchange Standards Consortium (CDISC), and the American Statistical Association (ASA).